Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity.
We assessed the pharmacokinetic characteristics of a new high-purity pasteurized FVIII concentrate in comparison with an intermediate purity pasteurized concentrate, produced by the same manufacturer. The study was designed as a cross-over single-dose pharmacokinetic investigation in 8 non-bleeding patients with severe hemophilia A. All patients were given 25 IU/kg of each of the two concentrates, with an interval of at least one week between the two administrations. Decay curves were assessed by collecting 10 serial blood samples over 36 hours following the end of infusion. The concentration of Factor VIII in blood samples was determined in triplicate in three different laboratories using each of the following assay methods: a one-stage clotting assay, a two-stage clotting assay, and a two-stage chromogenic-peptide substrate assay. All pharmacokinetic parameters were calculated by model-independent methods. The two products were found to differ significantly both in the clearance, which was on average 13.8% lower for Haemate P, and in the in-vivo recovery, which was 11.7% lower for Factor VIII:C P on the average. In comparison with previous pharmacokinetic data obtained from other heated Factor VIII concentrates, the clearance of Haemate P was found to be significantly slower, while the half-life of both products was longer. No differences were observed in the Vd-area. These findings indicate that the purification procedures to which both products are subjected do not increase the in-vivo rate of plasma disappearance of Factor VIII.
Messori
A
A
Hematology Depart. & Hemophilia Center, USL 10/D, Florence, Italy.
Morfini
M
M
Blomback
M
M
Cinotti
S
S
Longo
G
G
Schimpf
K
K
Schumacher
K
K
Novakova-Banet
A
A
Delvos
U
U
Kjellman
H
H
D000293:Adolescent; D000328:Adult; D001780:Blood Coagulation Tests; D002863:Chromogenic Compounds; D005169:Factor VIII / Q000493:pharmacokinetics*; D006467:Hemophilia A / Q000097:blood; D006358:Hot Temperature; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D015203:Reproducibility of Results; D013242:Sterilization / Q000379:methods
D002863:Chromogenic Compounds; D005169:Factor VIII